Sun Pharma is on the verge of acquiring US-based Organon for $12.5 billion, its largest deal ever. Organon's board is meeting this weekend to finalise the decision, with an announcement expected Sunday night or by Monday. Sun Pharma beat out a competing consortium of EQT and Gruenthal to clinch the deal. The deal structure splits into two parts: Sun Pharma pays $4.5 billion in equity and takes on $8.5 billion of Organon's existing debt. That debt load is the bigger number here, inheriting $8.5 billion means Sun's balance sheet will look very different after close, and investors will watch closely how the company plans to service and reduce it. Organon, spun off from Merck in 2021, focuses on women's health, biosimilars, and established branded medicines, areas that complement Sun Pharma's existing generics and specialty drug portfolio. The acquisition would significantly expand Sun's global footprint and product pipeline. The immediate questions are deal financing terms, any regulatory clearance hurdles across markets, and how Sun Pharma plans to manage the combined debt burden without squeezing its operating margins.
Flipkart will launch a food delivery pilot in Bengaluru by mid-August, charging restaurants a 10-11% commission compared to the 25-35% levied by Swiggy and Zomato. The move targets growing restaurant discontent with incumbent platforms and aims to drive daily engagement across Flipkart's 500 million registered users.
Maruti Suzuki crossed two lakh domestic units in July 2026 for the first time, recording 42.4% year-on-year growth. Total sales including exports and OEM supplies reached 2,41,421 units, with all passenger vehicle segments posting gains.
Air India's net loss more than doubled to ₹22,238 crore in FY26, prompting Tata Sons chairman N Chandrasekaran to extend the Vihaan.AI turnaround timeline from five years to as long as a decade.
UpGrad's all-stock acquisition of Unacademy, valued at Rs 1,955 crore, is set to close within three weeks after CCI clearance and near-complete investor sign-offs. The deal combines upGrad's upskilling business with Unacademy's test prep and medical education platforms, with Gaurav Munjal staying on as CEO.
